Antiperinuclear factor in juvenile rheumatoid arthritis

G. Nesher, T. L. Moore, M. W. Grisanti, E. El-Najdawi, Thomas Osborn

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The serological diagnosis of juvenile rheumatoid arthritis (JRA) is difficult, with only 7-10% of patients 19S IgM rheumatoid factor positive. About 60-70% of patients are positive for hidden 19S IgM rheumatoid factor, but this test requires serum separation and is not available in most laboratories. Antiperinuclear factor has been described in both seropositive and seronegative adult patients with rheumatoid arthritis, but has not been thoroughly evaluated in children with JRA. This study determined the diagnostic sensitivity and specificity of antiperinuclear factor in patients with JRA. Serum samples from 64 children with JRA, 24 with systemic lupus erythematosus (SLE), and 24 control subjects were tested for the presence of antiperinuclear factor. A total of 10 (83%) of seropositive, polyarticular onset and six (37%) of seronegative, polyarticular onset patients with JRA were positive for antiperinuclear factor. The occurrence of antiperinuclear factor in five (19%) with pauciarticular onset and one (10%) with systemic onset (JRA) as well as in four (17%) with SLE was not increased compared with the control subjects (1/24 (4%)). These data show an overall diagnostic sensitivity and specificity of 34 and 90% respectively in this group of patients. Although less sensitive than the hidden rheumatoid factor assay, the antiperinuclear factor assay is easier to perform and may contribute to the serological diagnosis of JRA.

Original languageEnglish (US)
Pages (from-to)350-352
Number of pages3
JournalAnnals of the Rheumatic Diseases
Volume51
Issue number3
DOIs
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

Juvenile Arthritis
Rheumatoid Factor
Systemic Lupus Erythematosus
Immunoglobulin M
Assays
Sensitivity and Specificity
Serum
antiperinuclear factor
Rheumatoid Arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Antiperinuclear factor in juvenile rheumatoid arthritis. / Nesher, G.; Moore, T. L.; Grisanti, M. W.; El-Najdawi, E.; Osborn, Thomas.

In: Annals of the Rheumatic Diseases, Vol. 51, No. 3, 01.01.1992, p. 350-352.

Research output: Contribution to journalArticle

Nesher, G, Moore, TL, Grisanti, MW, El-Najdawi, E & Osborn, T 1992, 'Antiperinuclear factor in juvenile rheumatoid arthritis', Annals of the Rheumatic Diseases, vol. 51, no. 3, pp. 350-352. https://doi.org/10.1136/ard.51.3.350
Nesher, G. ; Moore, T. L. ; Grisanti, M. W. ; El-Najdawi, E. ; Osborn, Thomas. / Antiperinuclear factor in juvenile rheumatoid arthritis. In: Annals of the Rheumatic Diseases. 1992 ; Vol. 51, No. 3. pp. 350-352.
@article{4f7119ab94e943878b42fd3af01b3dec,
title = "Antiperinuclear factor in juvenile rheumatoid arthritis",
abstract = "The serological diagnosis of juvenile rheumatoid arthritis (JRA) is difficult, with only 7-10{\%} of patients 19S IgM rheumatoid factor positive. About 60-70{\%} of patients are positive for hidden 19S IgM rheumatoid factor, but this test requires serum separation and is not available in most laboratories. Antiperinuclear factor has been described in both seropositive and seronegative adult patients with rheumatoid arthritis, but has not been thoroughly evaluated in children with JRA. This study determined the diagnostic sensitivity and specificity of antiperinuclear factor in patients with JRA. Serum samples from 64 children with JRA, 24 with systemic lupus erythematosus (SLE), and 24 control subjects were tested for the presence of antiperinuclear factor. A total of 10 (83{\%}) of seropositive, polyarticular onset and six (37{\%}) of seronegative, polyarticular onset patients with JRA were positive for antiperinuclear factor. The occurrence of antiperinuclear factor in five (19{\%}) with pauciarticular onset and one (10{\%}) with systemic onset (JRA) as well as in four (17{\%}) with SLE was not increased compared with the control subjects (1/24 (4{\%})). These data show an overall diagnostic sensitivity and specificity of 34 and 90{\%} respectively in this group of patients. Although less sensitive than the hidden rheumatoid factor assay, the antiperinuclear factor assay is easier to perform and may contribute to the serological diagnosis of JRA.",
author = "G. Nesher and Moore, {T. L.} and Grisanti, {M. W.} and E. El-Najdawi and Thomas Osborn",
year = "1992",
month = "1",
day = "1",
doi = "10.1136/ard.51.3.350",
language = "English (US)",
volume = "51",
pages = "350--352",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "3",

}

TY - JOUR

T1 - Antiperinuclear factor in juvenile rheumatoid arthritis

AU - Nesher, G.

AU - Moore, T. L.

AU - Grisanti, M. W.

AU - El-Najdawi, E.

AU - Osborn, Thomas

PY - 1992/1/1

Y1 - 1992/1/1

N2 - The serological diagnosis of juvenile rheumatoid arthritis (JRA) is difficult, with only 7-10% of patients 19S IgM rheumatoid factor positive. About 60-70% of patients are positive for hidden 19S IgM rheumatoid factor, but this test requires serum separation and is not available in most laboratories. Antiperinuclear factor has been described in both seropositive and seronegative adult patients with rheumatoid arthritis, but has not been thoroughly evaluated in children with JRA. This study determined the diagnostic sensitivity and specificity of antiperinuclear factor in patients with JRA. Serum samples from 64 children with JRA, 24 with systemic lupus erythematosus (SLE), and 24 control subjects were tested for the presence of antiperinuclear factor. A total of 10 (83%) of seropositive, polyarticular onset and six (37%) of seronegative, polyarticular onset patients with JRA were positive for antiperinuclear factor. The occurrence of antiperinuclear factor in five (19%) with pauciarticular onset and one (10%) with systemic onset (JRA) as well as in four (17%) with SLE was not increased compared with the control subjects (1/24 (4%)). These data show an overall diagnostic sensitivity and specificity of 34 and 90% respectively in this group of patients. Although less sensitive than the hidden rheumatoid factor assay, the antiperinuclear factor assay is easier to perform and may contribute to the serological diagnosis of JRA.

AB - The serological diagnosis of juvenile rheumatoid arthritis (JRA) is difficult, with only 7-10% of patients 19S IgM rheumatoid factor positive. About 60-70% of patients are positive for hidden 19S IgM rheumatoid factor, but this test requires serum separation and is not available in most laboratories. Antiperinuclear factor has been described in both seropositive and seronegative adult patients with rheumatoid arthritis, but has not been thoroughly evaluated in children with JRA. This study determined the diagnostic sensitivity and specificity of antiperinuclear factor in patients with JRA. Serum samples from 64 children with JRA, 24 with systemic lupus erythematosus (SLE), and 24 control subjects were tested for the presence of antiperinuclear factor. A total of 10 (83%) of seropositive, polyarticular onset and six (37%) of seronegative, polyarticular onset patients with JRA were positive for antiperinuclear factor. The occurrence of antiperinuclear factor in five (19%) with pauciarticular onset and one (10%) with systemic onset (JRA) as well as in four (17%) with SLE was not increased compared with the control subjects (1/24 (4%)). These data show an overall diagnostic sensitivity and specificity of 34 and 90% respectively in this group of patients. Although less sensitive than the hidden rheumatoid factor assay, the antiperinuclear factor assay is easier to perform and may contribute to the serological diagnosis of JRA.

UR - http://www.scopus.com/inward/record.url?scp=0026560738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026560738&partnerID=8YFLogxK

U2 - 10.1136/ard.51.3.350

DO - 10.1136/ard.51.3.350

M3 - Article

C2 - 1575580

AN - SCOPUS:0026560738

VL - 51

SP - 350

EP - 352

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 3

ER -